Restoration of immunity with interleukin-2 therapy

AIDS Read. 1999 Nov;9(8):563-72.

Abstract

HIV replication can now be effectively suppressed using antiretroviral combination regimens. The search continues, however, for ways to restore the immune response and eliminate reservoirs of latent infection. Interleukin-2 (IL-2) may augment the immune response in HIV-infected persons. This article discusses the rationale for using IL-2 in those with HIV disease and reviews key trials of IL-2 treatment regimens.

Publication types

  • Review

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Dose-Response Relationship, Drug
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • Humans
  • Immune System / drug effects*
  • Immunity / drug effects
  • Immunotherapy
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / pharmacology
  • Interleukin-2 / therapeutic use*
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology
  • Receptors, Interleukin-2 / drug effects
  • Receptors, Interleukin-2 / immunology
  • Virus Latency / drug effects
  • Virus Latency / immunology

Substances

  • Interleukin-2
  • Receptors, Interleukin-2